
Security Check Required




FacebookJoin or Log Into Facebook   Email or PhonePasswordForgot account?Log InDo you want to join Facebook?Sign UpSign UpSecurity CheckPlease enter the text belowCan't read the text above?Try another text or an audio captchaText in the box:What's this?Security CheckThis is a standard security test that we use to prevent spammers from creating fake accounts and spamming users.SubmitEnglish (US)EspañolFrançais (France)中文(简体)العربيةPortuguês (Brasil)Italiano한국어Deutschहिन्दी日本語MessengerFacebook LitePeoplePlacesGamesLocationsCelebritiesMarketplaceGroupsRecipesMomentsInstagramAboutCreate AdCreate PageDevelopersCareersPrivacyCookiesAd ChoicesTermsSettingsActivity Log Facebook © 2017





Insider Trading - Schaeffer Orlov S Nicole - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Schaeffer Orlov S Nicole





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-11-07Sale
2016-11-094:31 pm
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
68,774
$11.95
$821,931
37,500(Direct)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-11-07Exercise
2016-11-094:31 pm
N/AN/A
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
37,500
$6.96
37,500(Direct)
View


2016-11-07Exercise
2016-11-094:31 pm
N/AN/A
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
23,265
$6.96
37,500(Direct)
View


2016-11-07Exercise
2016-11-094:31 pm
N/AN/A
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
8,009
$6.96
37,500(Direct)
View


2016-11-07Exercise
2016-11-094:31 pm
N/A2023-01-02
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
37,500
$6.96
37,500(Direct)
View


2016-11-07Exercise
2016-11-094:31 pm
N/A2023-01-02
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
23,265
$6.96
37,500(Direct)
View


2016-11-07Exercise
2016-11-094:31 pm
N/A2023-01-02
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
8,009
$6.96
37,500(Direct)
View


2016-05-19Option Award
2016-05-234:56 pm
N/A2026-05-19
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
75,150
$10.85
75,150(Direct)
View


2016-01-07Option Award
2016-01-115:07 pm
N/A2026-01-07
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
50,000
$16.16
50,000(Direct)
View


2015-05-21Option Award
2015-05-265:18 pm
N/A2025-05-21
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
41,250
$22.76
41,250(Direct)
View


2015-02-26Option Award
2015-02-274:11 pm
2015-02-262023-05-23
Insmed Inc
INSM
Schaeffer Orlov S NicoleSVP, HR & Corp. Svcs.
12,500
$12.44
12,500(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 13:08:25 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










Insmed Incorporated - Statement of Changes of Beneficial Ownership






 







Print
Email
 PDF  WORD  XLS






 INSMED Inc (Form: 4, Received: 05/19/2017 16:36:35) 














	FORM 4




	[ ]
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.

	See

	Instruction 1(b).

	        





	UNITED STATES SECURITIES AND EXCHANGE COMMISSION

	Washington, D.C. 20549







	STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES



	                                                                                  




	OMB APPROVAL



	OMB Number:


	3235-0287



	Estimated average burden

	hours per response...


	0.5





	                      





	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940



	                      














	1. Name and Address of Reporting Person


	*






	Schaeffer Orlov S Nicole




	2. Issuer Name

	and

	Ticker or Trading Symbol




	INSMED Inc
	[
	INSM
	]




	5. Relationship of Reporting Person(s) to Issuer
	(Check all applicable)




	_____ Director

	                    

	_____ 10% Owner



	__

	X

	__ Officer (give title below)

	    

	_____ Other (specify below)




	SVP, HR & Corp. Svcs.








	(Last)

	        

	(First)

	        

	(Middle)





	10 FINDERNE AVENUE, BUILDING 10




	3. Date of Earliest Transaction

	(MM/DD/YYYY)






	5/17/2017








	(Street)





	BRIDGEWATER, NJ 08807



	(City)

	      

	(State)

	      

	(Zip)





	4. If Amendment, Date Original Filed


	(MM/DD/YYYY)





	 





	6. Individual or Joint/Group Filing


	(Check Applicable Line)




	_

	X

	_ Form filed by One Reporting Person

	___ Form filed by More than One Reporting Person















	Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned







	1.Title of Security

	(Instr. 3)




	2. Trans. Date




	2A. Deemed Execution Date, if any




	3. Trans. Code

	(Instr. 8)




	4. Securities Acquired (A) or Disposed of (D)

	(Instr. 3, 4 and 5)




	5. Amount of Securities Beneficially Owned Following Reported Transaction(s)

	(Instr. 3 and 4)




	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)




	7. Nature of Indirect Beneficial Ownership (Instr. 4)






	Code




	V




	Amount




	(A) or (D)




	Price


















	Table II - Derivative Securities Beneficially Owned (

	e.g.

	, puts, calls, warrants, options, convertible securities)







	1. Title of Derivate Security

	(Instr. 3)




	2. Conversion or Exercise Price of Derivative Security




	3. Trans. Date




	3A. Deemed Execution Date, if any




	4. Trans. Code

	(Instr. 8)




	5. Number of Derivative Securities Acquired (A) or Disposed of (D)

	(Instr. 3, 4 and 5)




	6. Date Exercisable and Expiration Date




	7. Title and Amount of Securities Underlying Derivative Security

	(Instr. 3 and 4)




	8. Price of Derivative Security

	(Instr. 5)




	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)




	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)




	11. Nature of Indirect Beneficial Ownership (Instr. 4)






	Code




	V




	(A)




	(D)




	Date Exercisable




	Expiration Date




	Title




	Amount or Number of Shares









	Stock Option

	 





	$17.16

	 





	5/17/2017

	 




	 





	A

	 





	  







	38300


	  




	  




	 


	(1)







	5/17/2027

	 





	Common Stock

	 





	38300

	 





	$0

	 





	38300

	 





	D

	 





	 














	Explanation of Responses:










	(1) 





	Stock options granted under the Company's 2015 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.













	Reporting Owners








	Reporting Owner Name / Address





	Relationships






	Director




	10% Owner




	Officer




	Other







	Schaeffer Orlov S Nicole

	10 FINDERNE AVENUE

	BUILDING 10

	BRIDGEWATER, NJ 08807












	SVP, HR & Corp. Svcs.

















	Signatures









	/s/ S. Nicole Schaeffer, by Christine Pellizzari as Attorney-in-fact








	5/19/2017









	**


	Signature of Reporting Person




	Date












	Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.








	*






	If the form is filed by more than one reporting person,

	see

	Instruction 4(b)(v).








	**






	Intentional misstatements or omissions of facts constitute Federal Criminal Violations.

	See

	18 U.S.C. 1001 and 15 U.S.C. 78ff(a).






	Note:




	File three copies of this Form, one of which must be manually signed. If space is insufficient,

	see

	Instruction 6 for procedure.






	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.













 








S. Nicole O. Schaeffer - Executive Bio, Compensation History, and Contacts - Equilar Atlas










 

















Log in | Sign up








x

 






As Featured In




















S. Nicole O. Schaeffer
Senior Vice President, Human Resources and Corporate Services at Insmed Incorporated


View Full Profile
Are you S. Nicole O. Schaeffer? Claim your profile


 


Sign up for Equilar Atlas and view S. Nicole O. Schaeffer's full profile. 
With Equilar Atlas, you can:



IDENTIFY corporate executives in S. Nicole O. Schaeffer's  network and community.
												FOLLOW changes in S. Nicole O. Schaeffer's employment and money-in-motion.
												CONNECT with S. Nicole O. Schaeffer through your network of contacts.
												








S. Nicole O. Schaeffer's Executive Work History


Current


Senior Vice President, Human Resources and Corporate Services, 
Insmed Incorporated


Past
To view S. Nicole O. Schaeffer's complete executive work history, sign up now
Age
48

 
 


S. Nicole O. Schaeffer's Biography



Ms. Schaeffer joined Insmed as Senior Vice President, Human Resources and Corporate Services in January 2013. From October through December 2012, Ms. Schaeffer was a consultant to Insmed. Ms. Schaeffer has more than 25 years of experience in human resources, organizational development, corporate operations, and building life science organizations. From March 2005 to June 2012, Ms. Schaeffer served as Senior Vice President, Administration and Human Resources, for Amicus Therapeutics (Nasdaq: FOLD) where she was responsible for the human resources, facilities, and information technology functions. Prior to Amicus, she served as Senior Director, ...
(Read More)

			Ms. Schaeffer joined Insmed as Senior Vice President, Human Resources and Corporate Services in January 2013. From October through December 2012, Ms. Schaeffer was a consultant to Insmed. Ms. Schaeffer has more than 25 years of experience in human resources, organizational development, corporate operations, and building life science organizations. From March 2005 to June 2012, Ms. Schaeffer served as Senior Vice President, Administration and Human Resources, for Amicus Therapeutics (Nasdaq: FOLD) where she was responsible for the human resources, facilities, and information technology functions. Prior to Amicus, she served as Senior Director, Human Resources, for three portfolio companies of Flagship Ventures, a venture capital firm, and in that capacity she managed human resources for three life sciences companies. Ms. Schaeffer has also held HR leadership positions with Oak Industries, from 1997 to 2000, and EMC Corporation, from 1994 to 1996. Ms. Schaeffer received her Bachelor of Arts degree from the University of Rochester and her Master of Business Administration degree from Boston University.
		
Source: Insmed Incorporated on 04/07/2017
		
	

 






Sign up for Equilar Atlas and view S. Nicole O. Schaeffer's full profile. 



												By accessing Equilar Atlas, you can view bios, network, salary and wealth events
												of industry-leading executives like S. Nicole O. Schaeffer. More specifically, you'll be able to:
												

IDENTIFY corporate executives in S. Nicole O. Schaeffer's  network and community.
												FOLLOW changes in S. Nicole O. Schaeffer's employment and money-in-motion.
												CONNECT with S. Nicole O. Schaeffer through your network of conections.
												




View Full Profile


 








Search for over 360,000 executive profiles.





/bio



													Example: S. Nicole O. Schaeffer


















S. Nicole O. Schaeffer's Connections (51)





Sign up now to view S. Nicole O. Schaeffer's 51 connections »









David J. Lockhart
Former Chief Scientific Officer, Amicus Therapeutics, Inc.









Christine A. Pellizzari
General Counsel and Secretary, Insmed Incorporated









Matthew Pauls
Board Member, Savara Inc.









William H. Lewis
Dir., President and Chief Executive Officer, Insmed Incorporated









Andrew T. Drechsler
Former Advisor and Former Chief Financial Officer, Insmed Incorporated









Melvin Sharoky
Board Member, Insmed Incorporated









William D. Baird
Chief Financial Officer, Amicus Therapeutics, Inc.









Margaret G. McGlynn
Board Member, Air Products









John F. Crowley
Chairman of the Board and Chief Executive Officer, Amicus Therapeutics, Inc.









Kenneth W. Peist
Former Vice President, Legal and Intellectual Property, Amicus Therapeutics, Inc.








Popular Profiles






														Sign up now to view more executive profiles »
														









Thomas J. Lynch
Executive Chairman, TE Connectivity Ltd.









John J. Kita
EVP and CFO, A. O. Smith









Carl G. Annessa
EVP and COO, Hornbeck Offshore Services, Inc.









Elon R. Musk
CEO and Chairman, Tesla









Michael C. Montgomery
Board Member, NMI Holdings, Inc.












×

Claim Your Profile Coming Soon
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.

Done


Thank you for your interest.
Ok






			Browse executive profiles:
			
				 A
			
				 B
			
				 C
			
				 D
			
				 E
			
				 F
			
				 G
			
				 H
			
				 I
			
				 J
			
				 K
			
				 L
			
				 M
			
				 N
			
				 O
			
				 P
			
				 Q
			
				 R
			
				 S
			
				 T
			
				 U
			
				 V
			
				 W
			
				 X
			
				 Y
			
				 Z



Equilar Homepage
Equilar Atlas
Equilar Insight
Equilar BoardEdge
Equilar Engage
Research Services
Knowledge Network
About Us
Login

ï¿½ 2017 Equilar All Rights Reserved. Privacy Policy
1100 Marshall Street, Redwood City, CA 94063 | Phone (650) 241-6600 | Fax (650) 701-0993
















Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft











Orlov S Nicole  Schaeffer - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Orlov S Nicole  Schaeffer
Check out list of companies and businesses related to Orlov S Nicole  Schaeffer. Find out Orlov S Nicole  Schaeffer address and contact details. View other people related to Orlov S Nicole  Schaeffer - coworkers, colleagues, companions, etc.
Address:   

C/O AMICUS THERAPEUTICS, INC. 6 CEDAR BROOK DRIVE CRANBURY 08512 NJ




Companies related to Orlov S Nicole  Schaeffer
CIKCompany NamePositionCompany Address0001104506INSMED IncSVP, HR & Corp. Svcs. 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER 088070001178879AMICUS THERAPEUTICS INCSVP, HR & Leadership Devt 1 CEDAR BROOK DRIVE  CRANBURY 08512




Orlov S Nicole  Schaeffer on the Web
Persons related to Orlov S Nicole  Schaeffer - INSMED IncNamePositionCityACM Capital Partners, LLCSAN FRANCISCORoger  AdsettChief Commercial Officer BRIDGEWATERGEOFFREY  ALLANPresident, CEO and Chairman GLEN ALLENGEOFFREY  ALLANPresident, CEO and Chairman RICHMONDALFRED  ALTOMARIDirector PRINCETONALFRED  ALTOMARIDirector MONMOUTH JUNCTIONALFRED  ALTOMARIDirector BRIDGEWATERAyer Capital Management, LPSAN FRANCISCOAyer Capital Partners, LLCSAN FRANCISCOPeggy  BerryVice President, Regulatory MONMOUTH JUNCTIONPeggy  BerryVice President, Regulatory BRIDGEWATERDavid R  BrennanDirector MONMOUTH JUNCTIONDavid R  BrennanDirector BRIDGEWATERKENNETH G  CONDONKENNETH G  CONDONDirector SUDBURYKENNETH G  CONDONDirector BOSTONKENNETH G  CONDONDirector GLEN ALLENKENNETH G  CONDONDirector SPRINGFIELDGRAHAM K  CROOKEDirector GLEN ALLENGRAHAM K  CROOKEDirector GLEN ALLENGRAHAM K  CROOKEDirector RICHMONDGRAHAM K  CROOKEDirector BOSTONGRAHAM K  CROOKEDirector RICHMONDHayden, Jr.  DonaldRichmondAndrew T  DrechslerChief Financial Officer CRANBURYAndrew T  DrechslerChief Financial Officer MONMOUTH JUNCTIONAndrew T  DrechslerChief Financial Officer MONMOUTH JUNCTIONAndrew T  DrechslerChief Financial Officer BRIDGEWATERAndrea Holtzman  DruckerMONMOUTH JUNCTIONAndrea Holtzman  DruckerSenior V.P., General Counsel MONMOUTH JUNCTIONAndrea Holtzman  DruckerSVP, Gen. Counsel & Corp Sec. MONMOUTH JUNCTIONMichael  DuncanGLEN ALLENMichael  DuncanPrincipal Financial Officer GLEN ALLENSTEINAR J  ENGELSENDirector GLEN ALLENSTEINAR J  ENGELSENDirector GLEN ALLENSTEINAR J  ENGELSENDirector RICHMONDSTEINAR J  ENGELSENDirector MONMOUTH JUNCTIONSTEINAR J  ENGELSENDirector MONMOUTH JUNCTIONSTEINAR J  ENGELSENDirector MONMOUTH JUNCTIONSTEINAR J  ENGELSENDirector BRIDGEWATERDoug  FarrarVice President, ITP RICHMONDFMR LLCBOSTONFMR LLC10% Owner BOSTONSteve C  GloverPresident Follow-on Biologics RICHMONDRONALD D  GUNNExecutive Vice President GLEN ALLENRONALD D  GUNNExecutive Vice President & COO GLEN ALLENRONALD D  GUNNRICHMONDRENU  GUPTAMONMOUTH JUNCTIONRENU  GUPTAEVP & Chief Medical Officer MONMOUTH JUNCTIONRENU  GUPTAEVP & Chief Medical Officer MONMOUTH JUNCTIONRENU  GUPTAEVP & Chief Medical Officer MONMOUTH JUNCTIONRENU  GUPTAExecutive Vice President & CMO MONMOUTH JUNCTIONNicholas Lee  GurreriMONMOUTH JUNCTIONNicholas Lee  GurreriSenior VP, Commercial Ops RICHMONDDONALD J  HAYDEN JRDirector PRINCETONDONALD J  HAYDEN JRDirector BRIDGEWATERDONALD J  HAYDEN JRMONMOUTH JUNCTIONDONALD J  HAYDEN JRDirector RICHMONDDONALD J  HAYDEN JRMONMOUTH JUNCTIONDONALD J  HAYDEN JRDirector MONMOUTH JUNCTIONDONALD J  HAYDEN JRDirector MONMOUTH JUNCTIONDONALD J  HAYDEN JRDirector MONMOUTH JUNCTIONGlen L  KelleyRICHMONDThomas A  KeuerVP, ITP (Subsidiary) GLEN ALLENThomas A  KeuerBOULDERThomas A  KeuerSr VP, ITP (Subsidiary) GLEN ALLENTully  KevinRichmondRichard S  KollenderDirector RICHMONDRichard S  KollenderDirector MONMOUTH JUNCTIONRichard S  KollenderDirector MONMOUTH JUNCTIONNicholas A. Jr.  LaBellaRICHMONDNicholas A. Jr.  LaBellaChief Scientific Officer RICHMONDNicholas A. Jr.  LaBellaChief Scientific Officer MONMOUTH JUNCTIONDennis M  LanfearRICHMONDDennis M  LanfearDirector RICHMONDWilliam  LewisPresident & CEO BRIDGEWATERWilliam  LewisPresident and CEO MONMOUTH JUNCTIONWilliam  LewisPresident and CEO MONMOUTH JUNCTIONWilliam  LewisPresident & CEO MONMOUTH JUNCTIONDAVID W J  MCGIRRDirector GREENWICHDAVID W J  MCGIRRMONMOUTH JUNCTIONDAVID W J  MCGIRRDirector MONMOUTH JUNCTIONDAVID W J  MCGIRRDirector BRIDGEWATERSharoky  MelvinRichmondLaBella  NicholasRichmondMatthew  PaulsMONMOUTH JUNCTIONMatthew  PaulsChief Commercial Officer MONMOUTH JUNCTIONMatthew  PaulsChief Commercial Officer MONMOUTH JUNCTIONCHRISTINE A  PELLIZZARIGeneral Counsel & Corp. Sec. MORRISTOWNChristine A  PellizzariGeneral Counsel & Secretary MONMOUTH JUNCTIONChristine A  PellizzariGeneral Counsel & Secretary MONMOUTH JUNCTIONChristine A  PellizzariGeneral Counsel & Secretary BRIDGEWATERMYRTLE S  POTTERDirector MYRTLE S  POTTERBRIDGEWATERMark  QuigleyVice President, Quality MONMOUTH JUNCTIONMark  QuigleyVice President, Quality BRIDGEWATERWhitcomb  RandallRichmondGupta  RenuRichmondOrlov S Nicole  SchaefferSVP, HR & Corp. Svcs. CRANBURYOrlov S Nicole  SchaefferSVP, HR & Corp. Svcs. MONMOUTH JUNCTIONOrlov S Nicole  SchaefferSVP, HR & Corp. Svcs. BRIDGEWATERMELVIN MD  SHAROKYDirector DAVIEMELVIN MD  SHAROKYDirector MONMOUTH JUNCTIONMELVIN MD  SHAROKYDirector MONMOUTH JUNCTIONMELVIN MD  SHAROKYDirector MONMOUTH JUNCTIONMELVIN MD  SHAROKYDirector BRIDGEWATERMELVIN MD  SHAROKYDirector GLEN ALLENMELVIN MD  SHAROKYDirector GLEN ALLENMELVIN MD  SHAROKYDirector RICHMONDANDREAS  SOMMERGLEN ALLENEngelsen  SteinarRichmondPAUL  STRECKChief Medical Officer BRIDGEWATEREUGENE JEFFREY  SULLIVANChief Med. & Scientific Ofc. BRIDGEWATERWhitten  TimothyRichmondPAOLO  TOMBESIChief Financial Officer BRIDGEWATERKEVIN P  TULLYGLEN ALLENKEVIN P  TULLYGLEN ALLENKEVIN P  TULLYGLEN ALLENKEVIN P  TULLYExecutive VP & CFO RICHMONDKEVIN P  TULLYExecutive VP & CFO MONMOUTH JUNCTIONJay  VenkatesanSAN FRANCISCORANDALL W  WHITCOMBDirector GLEN ALLENRANDALL W  WHITCOMBDirector GLEN ALLENRANDALL W  WHITCOMBDirector GLEN ALLENRANDALL W  WHITCOMBDirector RICHMONDRANDALL W  WHITCOMBDirector MONMOUTH JUNCTIONRANDALL W  WHITCOMBDirector MONMOUTH JUNCTIONRANDALL W  WHITCOMBDirector MONMOUTH JUNCTIONRANDALL W  WHITCOMBDirector BRIDGEWATERTimothy  WhittenMONMOUTH JUNCTIONTimothy  WhittenPresident & CEO RICHMONDTimothy  WhittenPresident & CEO MONMOUTH JUNCTIONTimothy  WhittenPresident & CEO MONMOUTH JUNCTIONTimothy  WhittenPresident & CEO MONMOUTH JUNCTIONPhilip J  YoungGLEN ALLENPhilip J  YoungChief Business Officer and EVP GLEN ALLENPhilip J  YoungGLEN ALLENPhilip J  YoungChief Business Officer and EVP GLEN ALLENPhilip J  YoungRICHMONDPersons related to Orlov S Nicole  Schaeffer - AMICUS THERAPEUTICS INCNamePositionCityBarkas  AlexanderCranburyKurt J.  AndrewsSVP, Human Resources CRANBURYWilliam D  Baird IIIChief Financial Officer CRANBURYMark  BaldryVP Global Marketing CRANBURYJOHN V  BALENWESTPORTSOL J  BARERDirector WARRENSOL J  BARERDirector CRANBURYSOL J  BARERDirector SUMMITALEXANDER E  BARKASDirector PALO ALTOM JAMES  BARRETTBALTIMOREM JAMES  BARRETTDirector TIMONIUMPETER J  BARRIS10% Owner BALTIMOREPETER J  BARRIS10% Owner TIMONIUMJay  BarthChief Medical Officer CRANBURYFOREST  BASKETTBALTIMOREFOREST  BASKETTTIMONIUMStephen M  BlochDirector WESTPORTStephen M  BlochDirector WESTPORTStephen M  BlochDirector WESTPORTPol F  BoudesChief Medical Officer CRANBURYPol F  BoudesChief Medical Officer CRANBURYCampbell  BradleyCranburyCampbell  BradleyCranburyDouglas A  BranchCRANBURYBradley L  CampbellChief Operating Officer CRANBURYBradley L  CampbellChief Operating Officer CRANBURYCANAAN EQUITY III ENTREPRENEURS LLCWESTPORTCANAAN EQUITY III LPWESTPORTCanaan Equity Partners III LLC10% Owner WESTPORTJeff  CastelliSVP, Program Management CRANBURYCHL Medical Partners II, L.P.10% Owner STAMFORDCHL Medical Partners II Side Fund, L.P.10% Owner STAMFORDWheeler  CraigCranburyJohn F  CrowleyChairman & CEO CRANBURYJohn F  CrowleyChairman & CEO CRANBURYQuimi  DaphneCranburyAllsop  DavidSVP International CRANBURYLockhart  DavidCranburyLockhart  DavidCranburyKAMRA  DEEPAKWESTPORTJames E  DentzerChief Financial Officer CRANBURYJames E  DentzerChief Financial Officer CRANBURYEnrique  DiloneSVP, Technical Operations CRANBURYEnrique  DiloneVP, Technical Operations CRANBURYHung  DoChief Science Officer CRANBURYHayden  DonaldCranburyHayden, Jr.  DonaldCranburyDipal  DoshiSVP Strategy & Bus Dev CRANBURYRYAN D  DRANTBALTIMORERYAN D  DRANTTIMONIUMJOSEPH  EDELMANJOSEPH  EDELMANNEW YORKJOSEPH  EDELMANNEW YORKDilone  EnriqueCranburyROBERT  ESSNERDirector MADISONROBERT  ESSNERDirector CRANBURYFHM IV LP10% Owner SEATTLEFHM IV LP10% Owner SEATTLEFHM V, LLCSEATTLEFHM V, LPSEATTLEFRAZIER AFFILIATES IV LPFRAZIER AFFILIATES IV LPSEATTLEFRAZIER HEALTHCARE IV LPSEATTLEFRAZIER HEALTHCARE IV LPFrazier Healthcare V, LPSEATTLEGarden State Life Sciences Venture Fund L P10% Owner PHILADELPHIAGilmore  GeoffreyCranburyJayne  GershkowitzSVP, Chief Patient Advocate CRANBURYGeoffrey  GilmoreSVP & General Counsel CRANBURYPLC  GLAXOSMITHKLINE10% Owner BRENTFORD MIDDLESEXPLC  GLAXOSMITHKLINE10% Owner BRENTFORD MIDDLESEX,Sblendorio  GlenCranburySblendorio  GlennCranburySblendorio  GlennCranburyJeremy  GreenSAN FRANCISCOL STEPHEN  GREENWESTPORTDONALD J  HAYDEN JRDirector PRINCETONDONALD J  HAYDEN JRDirector CRANBURYDONALD J  HAYDEN JRDirector CRANBURYRUSSELL C  HIRSCHPALO ALTORUSSELL C  HIRSCHPALO ALTOBarrett  JamesCranburyBarrett  JamesCranburyTopper  JamesCranburyTopper  JamesCranburyGerskowitz  JayneCranburyCastelli  JeffreyCranburyCastelli  JeffreyCranburyWinterbottom  JoanCranburyCrowley  JohnCranburyCrowley  JohnCranburyMcAdam M  JohnVP, Finance & Accounting CRANBURYKirk  JohnCranburyKirk  JohnCranburyValenzano  KenCranburyValenzano  KenCranburyPeist  KennethCranburyJohn  KirkVP, Regulatory Affairs CRANBURYJohn  KirkVP, Regulatory Affairs CRANBURYKRISHNA KITTU  KOLLURIBALTIMOREKRISHNA KITTU  KOLLURITIMONIUMGREGORY  KOPCHINSKYWESTPORTC RICHARD  KRAMLICH10% Owner BALTIMOREC RICHARD  KRAMLICH10% Owner TIMONIUMGregory P  LicholaiVP, Medical Affairs CRANBURYCHARLES M  LINEHANBALTIMOREDavid J  LockhartChief Scientific Officer CRANBURYDavid J  LockhartChief Scientific Officer CRANBURYTED W  LOVEDirector SUNNYVALETED W  LOVEDirector CRANBURYKarin  LudwigCRANBURYPeter M  MacalusoVP & Corporate Counsel CRANBURYMcGlynn  MargaretCranburyMcGlynn  MargaretCranburyPatterson  MatthewCranburyMARGARET G  MCGLYNNDirector WHITEHOUSE STATIONMARGARET G  MCGLYNNDirector CRANBURYMARGARET G  MCGLYNNDirector CRANBURYRaab  MichaelCranburyRaab  MichaelCranburyRaab  MichaelCranburySinai School of Medicine of New York University  MountNEW YORKNEA 11 GP, LLCBALTIMORENEA 11 GP, LLCTIMONIUMNEA PARTNERS 11 LPBALTIMORENEA PARTNERS 11 LPTIMONIUMP SHERRILL  NEFFDirector PHILADELPHIAP SHERRILL  NEFFDirector PHILADELPHIANEW ENTERPRISE ASSOCIATES 11 LPBALTIMORENEW ENTERPRISE ASSOCIATES 11 LP10% Owner TIMONIUMCHARLES W  NEWHALL III10% Owner BALTIMORECHARLES W  NEWHALL III10% Owner TIMONIUMNeff  PCranburyDavid  PallingSr VP, Technical Operations CRANBURYMatthew R  PattersonActing CEO & President CRANBURYKenneth  PeistVP, Legal & IP CRANBURYKenneth  PeistVP, Legal & IP CRANBURYPERCEPTIVE ADVISORS LLC10% Owner WASHINGTONPERCEPTIVE ADVISORS LLC10% Owner NEW YORKPERCEPTIVE LIFE SCIENCES MASTER FUND LTDWASHINGTONMARK W  PERRY10% Owner BALTIMOREMARK W  PERRY10% Owner TIMONIUMBoudes  PolCranburyBoudes  PolCranburyPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT ASSOCIATES II L PPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT MANAGEMENT CO II LLCPALO ALTOPROSPECT VENTURE PARTNERS II LP10% Owner PALO ALTOPROSPECT VENTURE PARTNERS II LPPALO ALTOQUAKER BIO VENTURES LP10% Owner PHILADELPHIADaphne  QuimiSVP, Finance CRANBURYDaphne  QuimiVP Finance and Controller CRANBURYMICHAEL  RAABDirector BALTIMOREMICHAEL  RAABBALTIMOREMICHAEL  RAABDirector BALTIMOREMICHAEL  RAABDirector CRANBURYMICHAEL  RAABDirector CRANBURYRedmile Group, LLC10% Owner SAN FRANCISCOEssner  RobertCranburyWinkler  RobertCranburyEllen  RosenbergGeneral Counsel & Corp. Secy CRANBURYSETH  RUDNICKWESTPORTGUY M  RUSSOWESTPORTSchaeffer  SCranburySCOTT D  SANDELLBALTIMORESCOTT D  SANDELLTIMONIUMGLENN  SBLENDORIODirector NEW YORKGLENN  SBLENDORIODirector CRANBURYGLENN  SBLENDORIODirector CRANBURYOrlov S Nicole  SchaefferSVP, HR & Leadership Devt CRANBURYDAVID  SCHNELLPALO ALTODAVID  SCHNELLPALO ALTOAndrew  ShenkerVP, Clinical Research CRANBURYMark  SimonCRANBURYBarer  SolCranburyBarer  SolCranburyJAMES B  TANANBAUMPALO ALTOJAMES B  TANANBAUMPALO ALTOLove  TedCranburyLove  TedCranburyJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector PALO ALTOJames N  TopperDirector MENLO PARKEUGENE A  TRAINOR IIIBALTIMOREKen  ValenzanoSVP, Pharmacology & Biology CRANBURYKen  ValenzanoVP, Pharmacology & Biology CRANBURYGregory M  WeinhoffDirector STAMFORDGregory M  WeinhoffDirector STAMFORDCRAIG A  WHEELERDirector EMERYVILLEBaird,  William IIICranburyRobert E  WinklerVP, Clin Research & Operations CRANBURYRobert E  WinklerVP, Clin Research & Operations CRANBURYJoan  WinterbottomSVP, Human Resources CRANBURYERIC A  YOUNGWESTPORTJulie  YuVP Clinical Ops & Data Mgmt CRANBURY












 









Schaeffer Orlov S Nicole Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      Schaeffer Orlov S Nicole
                    

•   CRANBURY, NJ
                      
How do I update this listing?




                                             Schaeffer Orlov S Nicole is based out of Cranbury.    WhaleWisdom has at least 1 insider transactions (Form 3,4,5) in our database for Schaeffer Orlov S Nicole. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from Schaeffer Orlov S Nicole, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




schaeffer orlov s nicole


C/O AMICUS THERAPEUTICS, INC.

CRANBURY
NJ
                                                        
                                                    08512


                                                      Business Phone:
                                                      (609) 662-2000
SEC SIC CODE:2834-PHARMACEUTICAL PREPARATIONS







Recent SEC Filings




4 filed on 05/19/2017
4 filed on 01/09/2017
4 filed on 11/09/2016
4 filed on 05/23/2016
4 filed on 01/11/2016
4 filed on 05/26/2015
4 filed on 02/27/2015
4 filed on 01/09/2015
3 filed on 06/04/2014
4 filed on 06/04/2014
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free

















